Incannex Healthcare (NASDAQ:IXHL – Get Free Report) announced its earnings results on Friday. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.13 by ($0.28), FiscalAI reports.
Incannex Healthcare Price Performance
Shares of Incannex Healthcare stock opened at $3.40 on Friday. Incannex Healthcare has a 1 year low of $2.49 and a 1 year high of $19.71. The stock has a fifty day moving average price of $3.29 and a 200-day moving average price of $3.47. The firm has a market cap of $40.70 million, a PE ratio of -2.19 and a beta of 6.97.
Analyst Ratings Changes
Several research firms have recently commented on IXHL. Alliance Global Partners assumed coverage on Incannex Healthcare in a report on Monday, June 8th. They set a “buy” rating and a $18.00 price objective for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Incannex Healthcare in a report on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Incannex Healthcare presently has an average rating of “Hold” and a consensus target price of $18.00.
About Incannex Healthcare
Incannex Healthcare Limited (NASDAQ: IXHL) is a clinical-stage biotechnology company developing pharmaceutical products and therapies for conditions with significant unmet medical needs. The company’s research focuses on cannabinoid- and psychedelic-assisted treatments, with programs addressing sleep-disordered breathing, pain, inflammation, mental health and other complex disorders.
One of Incannex’s principal programs is IHL-42X, an investigational combination of dronabinol and acetazolamide being developed for obstructive sleep apnea.
Further Reading
- Five stocks we like better than Incannex Healthcare
- Cintas Raises Guidance as a Major Catalyst Moves Closer
- 3 Space Stocks to Watch as SpaceX Reshapes the Launch Market
- Dave’s Success Has Investors Split
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
